Here are four things to know:
1. The market was valued at $2 billion in 2015.
2. The report notes the pain management devices market increases at three times the rate of the over-the counter internal analgesics segment as drug-free pain solutions are of increasing interest to consumers.
3. Technological advancements and expanding life spans have paved the way for market growth.
4. Pharmaceutical companies operating in the market include AstraZeneca, GlaxoSmithKline and Pfizer, among others.
More practice management news:
MGMA advocates for congressional oversight of CMMI: 5 notes
The last 30 years & counting — 5 key points on bundled payments
3 orthopedic clinics to pay $2.39M to settle False Claims Act allegations: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
